I wanted to post a few links that I found through the people who I follow on Twitter that I found interesting and useful. I tweet and retweet links that I find of value but I don’t always publish them on my blog, so I figured I would start doing so. Tom Murphy interview from HBS If you have read the book The Outsiders than you are familiar with Tom Murphy and the Capital Cities/ABC history. In this interview Tom Murphy provides a lot of good information about the history of Capital Cities and the philosophy and strategy that...
LeapFrog ($LF) Stock Analysis
LeapFrog Enterprises, Inc ($LF) is the maker of educational toys for children such as the LeapPad tablet for kids. The company classifies themselves as a leading developer of educational entertainment for children. The stock has struggled recently as the Christmas season has been deemed to be a concern for the industry and in particular LeapFrog. The main threat is the entrance of competition from some big names, Samsung and Amazon, who will be offering electronic tablets for children. LeapFrog’s Strategy The company’s strategy is to build high quality educational devices for children while offering a wide selection of digital...
Infusystems ($INFU) and the Round 1 Recompete Analysis
I’ve noticed a few more SeekingAlpha articles (here and here) discussing the investment in $INFU, including discussions about the result of the CMS Round 1 Recompete. If you would like to read more about the Recompete process, you can visit the CMS website. In a nutshell, the Durable Medical Equipment suppliers for patients using Medicare and Medicaid were included in the new Recompete (competitive bidding) process. The goal of the bidding process is to finalize a price for services and equipment that for reimbursement by the government. Each item category includes items listed in a Healthcare Common Procedure Coding System (HCPCS). So, the...
InfuSystem Holdings ($INFU) 2013 Annual Meeting
I took a few days off from work around Labor day to go visit my mom in Vermont. I hadn’t been back to Vermont for several years, so I wanted to get back before it was too cold for my liking. During this time, $INFU had their annual meeting. I did not attend the meeting since I was flying to Vermont, but would have liked to have gone. I would love to hear from anyone that attended the meeting and would like to give me a summary. Management also released an 8-k with an investor presentation attached! It is...
The Ultimate Guide to Stock Valuation Review
Jae Jun over at Old School Value has just released a free e-book on stock valuation methods. The name of the e-book is The Ultimate Guide to Stock Valuation and it covers 8 different techniques to calculate the value of a particular stock. The e-book is a great supplement to the Stock Analyzer product that is available for sale at Old School Value. By the way, I’m a user of the Stock Analyzer which I purchased a couple of years ago. 8 Valuation Techniques covered in the e-book: Net Net Working Capital and Net Current Asset Value Balance Sheet/Tangible asset...
InfuSystem Holdings Q2 2013 Review
$INFU released their 2013 Q2 earnings and completed their conference call. You can read the 10Q and conference call transcripts from the links. Since the recent failed take private situation, I wanted to review what is happening with the company. Positive Revenue up 4% from Q2 2012 Management has made strides in expanding their business model outside of the oncology market. Meaningful revenue was not shown this quarter, but it’s good to see that the company is expanding to other markets. Long-term care is one of markets, which is a good market to enter, along with post-surgical pain. These...
Ryan Morris makes his initial bid for INFU
Last night, Meson Capital Partners (i.e. Ryan Morris) filed the anticipated offer to purchase InfuSystems. The offer was for a price per share of between $1.85 to $2.00 in cash. I view this as an initial offer, as the price is at the low end of the range I was expecting. If you want to read the letter, click here and read the short letter. From the language in the letter, it sounds like a purchase can happen quickly if the special committee and Meson Capital can agree upon a satisfactory price. $INFU closed the day yesterday at $1.55...
Update on $INFU and Ryan Morris
Due to travel and my day job, I have not had a lot of time to keep up with the blog. Over the past weeks, I have been keeping track of my investments and potential ideas, but just haven’t had enough time to put something on the blog. It could also have to do with the stock market’s continual rise and not finding too many interesting ideas. I’ve written up InfuSystems ($INFU) awhile back and with the release of their latest quarterly earnings, some new developments have happened that create an interesting situation. First, the results for the first...